Navigation Links
Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy
Date:1/4/2012

olio at Genzyme and founding multiple life science and healthcare companies. 

"We are in a race against time to find safe and effective therapies for boys with DMD," said Benjamin Seckler, MD, President of Charley's Fund. "Our partnering with Nash Avery Foundation to establish Halo Therapeutics is the next step in the DMD patient community's tireless effort to find such a therapy. We're excited to have Gene and Marc, experienced drug development and biopharma industry business professionals, leading the company."

HT-100 works by inhibiting the pathological fibrotic process in muscle and directly stimulating healthy muscle fiber regeneration. The company has acquired an extensive data package on HT-100 including results of numerous animal model studies, a comprehensive toxicology package, and human clinical data from multiple trials in healthy volunteers and select disease populations.

Planning is well underway for clinical evaluation of the compound. CEO Marc Blaustein said, "We're extremely pleased that HT-100 has received orphan drug designation. This adds momentum to the significant progress we've made since our founding, and we are pressing forward to initiate a Phase II clinical trial in 2012 to evaluate HT-100 in DMD patients."About Duchenne Muscular DystrophyDuchenne muscular dystrophy is caused by a mutation in the dystrophin gene, resulting in progressive muscle weakness. The disease manifests itself first in weakened skeletal muscles and eventually results in cardiac and pulmonary impairment. Corticosteroids are the current standard of care treatment for DMD.  While this treatment delays disease progression by several years, their prolonged use is typically associated with side effects and the treatment does not alter the ultimate outcome of the disease. Young men with Duchenne typically live into their twenties or early thirties.

About Halo TherapeuticsBased in Newton, Mass., Halo Therapeutics, LLC, is a clinical
'/>"/>

SOURCE Halo Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Echo Therapeutics Announces $3.6 Million Warrant Exercises
2. Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco
3. Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock
4. AuraSense Therapeutics Secures Series B Equity Investment
5. PTC Therapeutics Antibacterial Program Receives $5 Million Award from the Wellcome Trust
6. Arecor Forms Collaboration With Lilly to Develop Advanced Formulations of Protein Therapeutics
7. Cerevast Therapeutics Receives CE Mark for Clotbust ER™ Ultrasound Stroke Treatment Device
8. Orexigen® Therapeutics Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
9. Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer
10. Cell Therapeutics, Inc. Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants
11. Pearl Therapeutics Reports Positive Phase 2b Results of PT001 in Patients With COPD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... N.J. and DETROIT , April ... five children live in poverty, the infant mortality rate is ... at 15 per 1,000 live births. Nearly 6 of 10 ... not receive adequate prenatal care.  These are sobering statistics that ... serving the people of Metro Detroit, is poised to change ...
(Date:4/17/2015)... 2015  Over the next five years, the marijuana industry ... ArcView predicting that 14 more states will legalize recreational marijuana ... market for legal cannabis grew 74 percent in 2014 to ... the market could grow more than fourfold to $11 billion ... stance on marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) ...
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
Breaking Medicine Technology:Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... Corporation (Nasdaq: DRRX ) announced today that ... the BIO CEO & Investor Conference on Monday, February ... being held at the Waldorf-Astoria Hotel in New York ... A live audio webcast of the presentation ...
... BD (Becton, Dickinson and Company) (NYSE: BDX ... that it signed a definitive agreement to acquire Accuri ... and manufactures personal flow cytometers for researchers.  The acquisition ... close during the third quarter of fiscal year 2011. ...
Cached Medicine Technology:DURECT to Present at the BIO CEO & Investor Conference 2BD Announces Agreement to Acquire Accuri Cytometers, Inc. 2BD Announces Agreement to Acquire Accuri Cytometers, Inc. 3
(Date:4/18/2015)... PHOENIX, ARIZONA – In March, Mark Ona, ... secure destruction professionals across the United States, earned the ... now display “CSDS” as a professional title with his ... Association of Information Destruction 2015 Annual Conference began - ... the 20 people who took the exam, Ona was ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant ... Week Celebration on April 20 with a day full ... body and soul. , The community, which is located ... adults of all incomes, including those on Medicaid, who ... Living Week is observed every April and highlights the ...
(Date:4/17/2015)... New York, NY (PRWEB) April 18, 2015 ... services at their facility, rounding out their list of ... comprehensive care center for patients on the Upper East ... up and running at full capacity. The addition of ... Accelerator, gives their physicians the ability to work with ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at ... were all selected as Top Workplaces in Tampa Bay. ... is ranked number one for large businesses according to ... in partnership with an independent research firm. Florida Hospital ... opened in October of 2012 with a vision of ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4
... 2008 A new study in the Journal of Communication ... resources helps patients more than simply providing a list of URLs ... women and is the second leading cause of cancer death among ... the study set out to examine what type of access to ...
... 100 Most Wired hospitals show,better outcomes in patient satisfaction, ... use of information technology (IT),according to a new analysis. ... Study continues to lead the field in analyses and,benchmarking ... promise in helping us improve the,quality and safety of ...
... 15, 2008 The Procter &,Gamble Company (NYSE: PG ... to June quarter of fiscal year 2007/08. The company,continues to ... 10,percent, organic sales growth in line with previous guidance and ... for the quarter are not yet available. P&G is scheduled,to ...
... On the Increase, FREDERICK, Md., July 15 ... the company will,resume airing an investment and product-related ... Andrew Whelan says,"We previously ran this commercial in ... and product awareness. We are excited to see,these ...
... Processes, Products, and Research Presented in ... HBA Technical Conference Program, ... thinking,access to new innovation and recognition of the need for ... Expo Educational Program is more robust than ever.,More than 200 ...
... shown an association between certain past diagnostic radiation procedures ... a rare form of prostate cancer which affects about ... disease. , The study, the first of its kind ... from diagnostic procedures and the risk of prostate cancer, ...
Cached Medicine News:Health News:Focused Internet services provide better support to breast cancer patients 2Health News:Patient Satisfaction Higher at Most Wired Hospitals 2Health News:Patient Satisfaction Higher at Most Wired Hospitals 3Health News:Procter & Gamble Confirms Prior Sales and Earnings Guidance for Fourth Quarter 2007/08 2Health News:Procter & Gamble Confirms Prior Sales and Earnings Guidance for Fourth Quarter 2007/08 3Health News:BioElectronics Corporation's Commercial Resumes on Bloomberg Television 2Health News:BioElectronics Corporation's Commercial Resumes on Bloomberg Television 3Health News:R&D and Regulatory Leaders in the Cosmetics/Personal Care Field Present Latest Industry Research at HBA Global Expo 2Health News:R&D and Regulatory Leaders in the Cosmetics/Personal Care Field Present Latest Industry Research at HBA Global Expo 3Health News:Possible link found between X-rays and prostate cancer 2
... is a handheld, noninvasive ultrasound instrument that ... operate, so any staff member can scan ... images from exams and print BVI 6100 ... just log on to ScanPoint®, Diagnostic Ultrasound's ...
... The Mobile BladderScan® BVI 6400 calculates ... ultrasound technology. V-MODE® ultrasound is accurate, ... seconds, the BladderScan® measures ultrasonic reflections ... planes, creates a 3-dimensional image of ...
... EXP Injectable Bulking Agent is ... suspended in a water-based carrier ... Agent is indicated for the ... stress urinary incontinence due to ...
... The MIS is designed to ... in the area of the mid-urethra. ... 30 minutes, and can be performed ... department which allows the patient to ...
Medicine Products: